Lobbying activity

Q2

PRIME THERAPEUTICS for PRIME THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · House · Senate

Health Issues, Medicare/Medicaid

View → Q2

ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations

View → Q1

WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code

View → Q1

AMERICAN COLLEGE OF RHEUMATOLOGY for AMERICAN COLLEGE OF RHEUMATOLOGY

1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate

Health Issues, Budget/Appropriations, Medicare/Medicaid

View → Q1

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q1

PRIME THERAPEUTICS for PRIME THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate

Health Issues, Medicare/Medicaid

View → Q1

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $450,000.00 income

Copyright/Patent/Trademark, Health Issues

View → Q1

AMGEN, INC. for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q1

THORN RUN PARTNERS for THE BIOSIMILARS FORUM

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $100,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations

View → Q1

MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → Q4

WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code

View → Q4

NATIONAL TAXPAYERS UNION for NATIONAL TAXPAYERS UNION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Transportation, Defense, Energy/Nuclear, Budget/Appropriations

View → Q4

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q4

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate

Medicare/Medicaid, Health Issues, Manufacturing, Copyright/Patent/Trademark

View → Q4

AMERICAN COLLEGE OF RHEUMATOLOGY for AMERICAN COLLEGE OF RHEUMATOLOGY

4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate

Health Issues, Budget/Appropriations, Medicare/Medicaid

View → Q4

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

AMGEN, INC. for AMGEN INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q4

THORN RUN PARTNERS for THE BIOSIMILARS FORUM

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $100,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q4

PRIME THERAPEUTICS for PRIME THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) 2025 · Minnesota · House · Senate

Health Issues, Medicare/Medicaid

View → Q4

SIGHTLINE ADVOCACY, LLC for AMGEN

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $20,000.00 income

Health Issues

View → 3A

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate

Trade (domestic/foreign), Medicare/Medicaid, Health Issues, Manufacturing

View →